Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Conversion of Discoid Lupus to Antiphospholipid Syndrome and SLE
Link ID 4997
Title Conversion of Discoid Lupus to Antiphospholipid Syndrome and SLE
Url http://www.medscape.com/viewarticle/572791?src=rss
Description A rare conversion of discoid lupus to antiphospholipid syndrome and systemic lupus erythematosus is presented in a 64-year-old man. What are the related diagnostic and management challenges?
Nature Clinical Practice Rheumatology
Category Articles > Rheumatology
Keywords
Date Apr 18, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Methotrexate Might Lower Cardiovascular Disease RiskMethotrexate Might Lower Cardiovascular Disease
  Rheumatoid arthritis (RA) patients treated with methotrexate might have a lower risk of cardiovascular disease, according to a recent report of findings from a meta-analysis. Reuters Health Information
Category:   Articles > Rheumatology


2. Evolving an Understanding of the Definition of Fibromyalgia by Assessing Potential Genetic and Imagi
  Dr. Simon discusses advancements in understanding fibromyalgia by using genetic and imaging markers, an update from ACR 2007.
Medscape Rheumatology
Category:   Articles > Rheumatology


3. Spondyloarthropathy Treatment Linked With Change in Body Composition
  Spondyloarthropathy patients who receive anti-tumor necrosis factor (TNF) therapy experience significant changes in body composition, according to a report in the May issue of The Journal of Rheumatology. Reuters Health Information
Category:   Articles > Rheumatology


4. Speaking Off Label
  This article explores the ethical, legal, and practical issues surrounding the off label use of drugs. The Hastings Center Report
Category:   Articles > Rheumatology


5. Adalimumab and Etanercept Edge Infliximab in RA Therapy
  Among tumor necrosis factor alpha blockers, adalimumab and etanercept appear to be more effective and less expensive than infliximab for treatment of patients with rheumatoid arthritis (RA), Dutch researchers report in the September issue of Annals of the Rheumatic Diseases. Reuters Health Information
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS